Jefferies Reiterates Buy Rating on Nektar Therapeutics (NKTR)
Go back to Jefferies Reiterates Buy Rating on Nektar Therapeutics (NKTR)| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 76.08 +2.44 (3.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $73.64 | 52 Week High | $19.98 | |||
| Open | $75.00 | 52 Week Low | $10.52 | |||
| Day High | $76.22 | P/E | N/A | |||
| Day Low | $73.43 | EPS | $-1.45 | |||
| Volume | 727,438 | |||||

